Symptoms of mast cell activation syndrome in functional gastrointestinal disorders
| Autor: | Asbjørn Mohr Drewes, Clive H. Wilder-Smith, Søren Schou Olesen, Andrea Materna |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male Adolescent Gastrointestinal Diseases Mast cell activation syndrome Young Adult 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine Humans Irritable bowel syndrome Aged Aged 80 and over irritable bowel syndrome business.industry Gastroenterology Middle Aged functional dyspepsia Mast cell medicine.disease medicine.anatomical_structure chemistry 030220 oncology & carcinogenesis Immunology Female 030211 gastroenterology & hepatology Symptom Assessment medicine.symptom mast cell business Mastocytosis Histamine |
| Zdroj: | Wilder-Smith, C H, Drewes, A M, Materna, A & Olesen, S S 2019, ' Symptoms of mast cell activation syndrome in functional gastrointestinal disorders ', Scandinavian Journal of Gastroenterology, vol. 54, no. 11, pp. 1322-1325 . https://doi.org/10.1080/00365521.2019.1686059 |
| ISSN: | 1502-7708 0036-5521 |
| Popis: | Objectives: Mast cell involvement is evident in functional gastrointestinal disorders (FGID). FGID and mast cell activation syndrome (MCAS) are associated with multi-organ symptoms. An overlap has not been assessed.Methods: MCAS symptoms were determined by questionnaires in 2083 FGID patients.Results: The median number of MCAS symptoms ([IQR] (range 0-16)) was 6 [4-8] in all FGID, and in functional dyspepsia (FD) patients, 7 [5-9] in overlapping irritable bowel syndrome and FD (IBS+FD), 5 [3-8] in IBS and 5 [3-6] in non-IBS/non-FD (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|